2017 - Member of the National Academy of Engineering For pioneering advances in cellular, tissue, and organ engineering and for leadership in applying metabolic engineering to human health.
2015 - Fellow, National Academy of Inventors
1993 - Fellow of the Indian National Academy of Engineering (INAE)
His primary areas of investigation include Cell biology, Hepatocyte, Immunology, Cell culture and Cell. His Cell biology research is multidisciplinary, incorporating perspectives in Microfluidics, Albumin, Cellular differentiation and Keratinocyte growth factor. His study in the fields of Bioartificial liver device under the domain of Hepatocyte overlaps with other disciplines such as Liver cytology.
His biological study spans a wide range of topics, including Fibroblast, Cancer research, Mesenchymal stem cell and Oxygene. Martin L. Yarmush works mostly in the field of Cell culture, limiting it down to topics relating to In vivo and, in certain cases, Pharmacology, Internal medicine and Endocrinology. His Cell research incorporates themes from T cell and Nanotechnology.
Martin L. Yarmush mostly deals with Cell biology, Hepatocyte, Biochemistry, Immunology and Pathology. His studies in Cell biology integrate themes in fields like Cell, Embryonic stem cell and Cellular differentiation. His Hepatocyte study incorporates themes from Cell culture and Internal medicine, Albumin, Endocrinology.
His research integrates issues of Molecular biology and In vitro in his study of Cell culture. His Immunology study combines topics in areas such as Cancer research and Mesenchymal stem cell. Martin L. Yarmush has included themes like Liver transplantation, Transplantation, Wound healing, Perfusion and In vivo in his Pathology study.
Martin L. Yarmush mainly investigates Cell biology, Transplantation, Pathology, Wound healing and Hepatocyte. The Cell biology study combines topics in areas such as Cell, In vitro, Induced pluripotent stem cell and In vivo. Martin L. Yarmush has researched Cell in several fields, including Decellularization and Cryopreservation.
Wound healing is a subfield of Immunology that Martin L. Yarmush investigates. His research in Hepatocyte intersects with topics in Cell culture, Drug metabolism, Hepatic stellate cell, Reactive oxygen species and Toxicity. His studies deal with areas such as Microfluidics and Cellular differentiation as well as Cell culture.
Cell biology, In vivo, Pathology, Decellularization and Nanotechnology are his primary areas of study. His Cell biology study integrates concerns from other disciplines, such as Human liver, In vitro, Immunology and Transplantation. His Immunology research incorporates elements of Genetically Engineered Mouse and Prostate cancer.
The study incorporates disciplines such as Wound healing, Regenerative medicine, Gene knockdown and Regeneration in addition to Pathology. His work is dedicated to discovering how Decellularization, Cell are connected with Induced pluripotent stem cell and Biomedical engineering and other disciplines. In general Nanotechnology study, his work on Microfluidics often relates to the realm of Microfabrication, thereby connecting several areas of interest.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix
Basak E. Uygun;Alejandro Soto-Gutierrez;Alejandro Soto-Gutierrez;Hiroshi Yagi;Hiroshi Yagi;Maria Louisa Izamis.
Nature Medicine (2010)
Effect of cell–cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells
S. N. Bhatia;U. J. Balis;M. L. Yarmush;M. Toner.
The FASEB Journal (1999)
Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration.
James C. Y. Dunn;Martin L. Yarmush;Hans G. Koebe;Ronald G. Tompkins.
The FASEB Journal (1989)
Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration.
James C. Y. Dunn;Ronald G. Tompkins;Martin L. Yarmush;Martin L. Yarmush.
Biotechnology Progress (1991)
Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure.
Biju Parekkadan;Biju Parekkadan;Daan van Poll;Daan van Poll;Kazuhiro Suganuma;Edward A. Carter.
PLOS ONE (2007)
Mesenchymal stem cells: Mechanisms of immunomodulation and homing.
Hiroshi Yagi;Alejandro Soto-Gutierrez;Biju Parekkadan;Yuko Kitagawa.
Cell Transplantation (2010)
Controlling cell interactions by micropatterning in co-cultures: hepatocytes and 3T3 fibroblasts.
Sangeeta N. Bhatia;Martin L. Yarmush;Mehmet Toner.
Journal of Biomedical Materials Research (1997)
Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo.
Daan van Poll;Daan van Poll;Biju Parekkadan;Biju Parekkadan;Cheul H. Cho;François Berthiaume.
Tissue engineering and regenerative medicine: history, progress, and challenges.
François Berthiaume;Timothy J. Maguire;Martin L. Yarmush.
Annual Review of Chemical and Biomolecular Engineering (2011)
Effect of Hypoxia on Insulin Secretion by Isolated Rat and Canine Islets of Langerhans
K. E. Dionne;C. K. Colton;Martin Yarmush.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: